Category: Artificial Intelligence

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

The civil monetary penalties for violations of countless healthcare laws are on the rise. A few months back, we discussed the sharp increase in penalties under the Federal False Claims ACT (FCA). With the initiation of an interim final rule, the per-claim FCA penalty was nearly doubled by the Department of Justice. The reason behind […]

The EFPIA Transparency Directive deems it necessary for all member associations within the EU to publish spend data by Pharma manufacturers on HCP/HCO. For this purpose, under the data privacy laws of the EU, it is necessary for pharmaceutical manufacturers to receive consent from HCPs prior to reporting any transfer of value details in the […]

The 4th Annual Pharma Compliance Europe Congress is being held at the Royal Garden Hotel, London, UK, on October 5th & 6th, 2016. The conference aims to bring together senior representatives from the legal, compliance, and transparency industries to discuss operational best practices and will feature an impressive list of speakers and attendees from Pfizer, […]

In the past couple of years, law enforcement agencies have recovered billions of dollars through judgments and settlements related to healthcare fraud investigations. In the fiscal year 2015, the DoJ recovered more than $3.5 billion in judgments and settlements from cases that involved fraud and false claims against the government. As time goes by, government […]

Data is the buzzword these days. With the vast amounts of healthcare data held by the Centers for Medicare & Medicaid Services (CMS), the organization has deemed it necessary to move away from the generic data scientist role to a specific big-data-related role to enhance healthcare delivery and detect cases of fraud through efficient statistical […]

Open Payments is a national program that is focused on promoting transparency by making data on the financial relationships between the healthcare industry (applicable manufacturers and group purchasing organizations or GPOs) and healthcare providers (physicians and teaching hospitals) publicly available. With such extensive data published every year, enforcement authorities have literally acquired a gateway to […]